Rhode Island Hospital
18 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 4 name spellings.
4
Ending by 2030
Aug 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 27, 2026The maintenance fee for Cartilage-Derived Mesenchymal Cell Lines (US 11,685,898) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 3 fees due Jan 4 to 18, 2027 · next Jan 4
- 2 fees due Aug 9 to 11, 2027 · next Aug 9
- 2 fees due Sep 15 to 19, 2027 · next Sep 15
- 1 fee due Oct 12, 2027The maintenance fee for Treatment, prevention, and reversal of alcohol-induced brain disease (US 9,308,198) comes due Oct 12, 2027. Unpaid by Apr 12, 2028, it lapses early.
Recent changes
- 4 of the patents on this record were granted since Aug 23, 2026
- Nov 17 US 12,797,441 VEGF Gene Therapy for Tendon and Ligament Injuries
- Nov 3 US 12,780,805 Nitrophenyl-Acrylamides and Uses Thereof
- Sep 29 US 12,748,114 Diagnosis, Prognosis and Treatment of Malignant Neoplasms
- Sep 29 US 12,746,092 Hydrogel-Based Ultrasonography Probe Stabilizer
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,914,583 | Wrist implants In force · USPTO record | In force | USPTO record | |
| US 7,918,894 | Kinematic total wrist arthroplasty In force · USPTO record | In force | USPTO record | |
| US 9,308,198 | Treatment, prevention, and reversal of alcohol-induced brain disease In force · USPTO record | In force | USPTO record | |
| US 9,687,537 | Dendritic cell vaccines for asparaginyl-β-hydroxylase expressing tumors In force · USPTO record | In force | USPTO record | |
| US 8,977,362 | Peripheral Pain Management In force · High confidence | In force | High confidence | |
| US 9,486,632 | Pain management In force · USPTO record | In force | USPTO record | |
| US 9,283,264 | Schistosoma vaccine In force · USPTO record | In force | USPTO record | |
| US 10,130,687 | Compositions and methods for the treatment of orthopedic disease or injury In force · USPTO record | In force | USPTO record | |
| US 8,708,825 | Device controller with conformable fitting system In force · USPTO record | In force | USPTO record | |
| US 9,572,787 | Inhibition of renal fibrosis In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 52: 18 patents in force now held by others · 17 lapsed for an unpaid fee · 40 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
24 pending · 16 abandoned · 24 no status recorded